Exelixis

$22.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.82 (+3.85%) Today

-$0.14 (-0.63%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Exelixis and other stocks, options, and ETFs commission-free!

About EXEL

Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA. The listed name for EXEL is Exelixis, Inc. Common Stock.

CEO

Michael M. Morrissey

Employees

617

Headquarters

Alameda, California

Founded

1994

Market Cap

7.16B

Price-Earnings Ratio

46.27

Dividend Yield

—

Average Volume

3.31M

High Today

$22.29

Low Today

$21.13

Open Price

$21.24

Volume

3.73M

52 Week High

$27.80

52 Week Low

$13.67

Collections

Analyst Ratings

75%

of 12 ratings

Buy

75%

Hold

25%

Sell

EXEL Earnings

$0.00

$0.11

$0.23

$0.34

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 10, After Hours